Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
antibodies
Research
Innate antibody pits NK cells against lymphoma in animal models
The antibody, called IPH6501, is now being evaluated in a phase 1/2 trial in patients with relapsed or unresponsive B cell non-Hodgkin lymphoma.
Darren Incorvaia
Nov 15, 2024 2:00pm
Dotmatics debuts antibody engineering R&D software platform
Oct 22, 2024 2:06pm
COVID antibodies shut down variants, earn $35M BARDA bucks
Oct 9, 2024 2:00pm
GigaGen garners up to $135M BARDA bucks to beat botulism
Oct 3, 2024 8:00am
Trispecific antibody one-ups Tecvayli in myeloma mouse study
Sep 17, 2024 3:38pm
Diagonal launches with $128M to grow agonist antibody platform
Apr 3, 2024 6:00am